PetVivo (PETV) Competitors $0.80 0.00 (0.00%) As of 02:33 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock PETV vs. BDMD, EDAP, APYX, NTRB, TELA, LUNG, QTI, VANI, ICCM, and CTSOShould you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Baird Medical Investment (BDMD), Edap Tms (EDAP), Apyx Medical (APYX), Nutriband (NTRB), TELA Bio (TELA), Pulmonx (LUNG), QT Imaging (QTI), Vivani Medical (VANI), IceCure Medical (ICCM), and Cytosorbents (CTSO). These companies are all part of the "medical equipment" industry. PetVivo vs. Its Competitors Baird Medical Investment Edap Tms Apyx Medical Nutriband TELA Bio Pulmonx QT Imaging Vivani Medical IceCure Medical Cytosorbents PetVivo (NASDAQ:PETV) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership. Is PETV or BDMD more profitable? Baird Medical Investment has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Baird Medical Investment's return on equity of 0.00% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets PetVivo-902.82% -4,813.07% -281.78% Baird Medical Investment N/A N/A N/A Do insiders and institutionals believe in PETV or BDMD? 24.5% of PetVivo shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable valuation and earnings, PETV or BDMD? Baird Medical Investment has lower revenue, but higher earnings than PetVivo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetVivo$1.05M21.34-$10.95M-$0.40-2.00Baird Medical InvestmentN/AN/AN/AN/AN/A Which has more risk and volatility, PETV or BDMD? PetVivo has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -0.97, meaning that its share price is 197% less volatile than the S&P 500. Does the media refer more to PETV or BDMD? In the previous week, PetVivo had 2 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for PetVivo and 0 mentions for Baird Medical Investment. PetVivo's average media sentiment score of 0.60 beat Baird Medical Investment's score of 0.00 indicating that PetVivo is being referred to more favorably in the media. Company Overall Sentiment PetVivo Positive Baird Medical Investment Neutral SummaryPetVivo beats Baird Medical Investment on 5 of the 9 factors compared between the two stocks. Get PetVivo News Delivered to You Automatically Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PETV vs. The Competition Export to ExcelMetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.32M$81.72M$5.76B$9.85BDividend YieldN/AN/A6.71%4.51%P/E Ratio-1.7811.3659.1122.53Price / Sales21.3497.89547.00119.09Price / CashN/A18.4137.0558.92Price / Book-26.679.1210.916.06Net Income-$10.95M-$26.48M$3.29B$266.28M7 Day PerformanceN/A0.33%0.01%-0.76%1 Month Performance0.13%8.23%7.06%3.83%1 Year Performance8.11%77.81%50.09%24.39% PetVivo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PETVPetVivoN/A$0.80flatN/A-2.4%$22.32M$1.05M-1.7820Gap DownBDMDBaird Medical InvestmentN/A$2.37-3.3%N/AN/A$87.54MN/A0.00N/AEDAPEdap Tms2.5304 of 5 stars$2.76+22.1%$8.50+208.0%-21.2%$84.51M$63.02M-4.52230News CoverageShort Interest ↑Analyst RevisionHigh Trading VolumeAPYXApyx Medical1.571 of 5 stars$1.92-3.5%N/A+40.7%$75.26M$48.10M-4.27270Positive NewsGap DownNTRBNutriband2.7065 of 5 stars$6.17-4.6%$13.00+110.7%+34.8%$72.11M$2.14M-6.8610Short Interest ↑Gap DownTELATELA Bio2.379 of 5 stars$1.74-2.2%$4.50+158.6%-40.2%$70.52M$69.30M-1.55120Positive NewsLUNGPulmonx3.8506 of 5 stars$1.73+1.2%$7.66+343.0%-74.5%$69.68M$83.79M-1.21250News CoverageQTIQT ImagingN/A$2.52+3.3%N/A+261.1%$68.38M$4.00M0.00N/APositive NewsGap UpVANIVivani Medical3.0229 of 5 stars$1.16+0.9%$4.00+244.8%-5.7%$68.13MN/A-2.5820News CoverageAnalyst ForecastShort Interest ↓Gap UpICCMIceCure Medical3.2708 of 5 stars$1.08-3.6%$2.39+120.8%+63.4%$65.74M$3.29M-6.7560News CoveragePositive NewsShort Interest ↓CTSOCytosorbents2.1642 of 5 stars$0.95+0.7%$5.50+478.8%-3.9%$59.21M$35.60M-5.59220Positive News Related Companies and Tools Related Companies BDMD Alternatives EDAP Alternatives APYX Alternatives NTRB Alternatives TELA Alternatives LUNG Alternatives QTI Alternatives VANI Alternatives ICCM Alternatives CTSO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PETV) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is hereWashington just added $1 trillion to the national debt in less than two months — an astonishing pace of spendi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetVivo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetVivo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.